ArticleFrontiers in endocrinology2026
Factors influencing abnormal cleavage of early embryos: time-lapse imaging analysis of 138,178 normally fertilized embryos.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- First cleavage signatures define a temporal trade-off and predict embryo fitness.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgrounds: Abnormal cleavage (ABNCL) in early human embryos is a frequent phenomenon associated with impaired developmental competence and reduced reproductive potential. However, the clinical determinants of ABNCL and its subtypes remain insufficiently defined. This study aimed to identify patient- and treatment-related factors associated with ABNCL in embryos generated through Methods: This retrospective cohort included 138,178 normally fertilized embryos cultured in a time-lapse imaging (TLI) system, comprising 77,260 normal cleavage (NC) and 60,918 ABNCL embryos. Univariate, stratified, and multivariable logistic regression with generalized estimating equation (GEE) analyses were performed to evaluate the associations between clinical characteristics-including demographics, controlled ovarian stimulation (COS) parameters, and insemination methods-and ABNCL occurrence and its subtypes. ABNCL was classified into direct cleavage (DC; including DC1 and DC2), rapid cleavage (RC), chaotic cleavage (CC), and other atypical patterns according to established morphokinetic criteria. Results: Among the 138,178 embryos analyzed, 55.9% exhibited NC and 44.1% demonstrated ABNCL. Stratified analyses revealed significant variability in ABNCL rates across baseline characteristics and stimulation-related factors. In GEE models, endometriosis, unexplained infertility, higher oocyte yield, intracytoplasmic sperm injection (ICSI), and rescue ICSI were independently associated with an increased risk of ABNCL. Conversely, the use of a mild stimulation protocol and higher estradiol (E2) levels on the hCG trigger day were linked to a reduced risk. Subtype analyses showed distinct factor-specific patterns: higher total gonadotropin (Gn) doses increased the likelihood of DC and "other" ABNCL types, while elevated initial Gn doses were associated with higher risks of RC and CC. Additionally, the gonadotropin-releasing hormone antagonist protocol specifically increased the risks of RC and "other" ABNCL patterns. Conclusions: ABNCL is a common event during early embryo development and is significantly influenced by both patient characteristics and treatment strategies. Endometriosis, unexplained infertility, higher oocyte yield, ICSI, and rescue ICSI were associated with increased ABNCL risk, whereas mild stimulation and higher E2 levels on the trigger day appeared protective. These findings underscore the importance of individualized COS and fertilization strategies to promote optimal early embryo development in assisted reproductive technology; however, their implications are limited to cleavage-stage outcomes and should not be extrapolated to later developmental or clinical endpoints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.